Swedencare publ AB (SECARE)
Stockholm Exchange · Sweden · prices in SEK · close of 20 Oct 2026
Key indicators
| Last close | SEK 23.55 |
|---|---|
| 52-week range | 20.65 – 41.51 |
| Return, 1 month / 3 months | +10.3% / +9.0% |
| Return, 1 year / 3 years | −26.4% / −37.9% |
| Trend | Below its 200-day average |
| RSI (14) | 64 |
| Volatility (1 year) | 53.2% |
| Worst drawdown (1 year) | -47.1% |
| Average daily value traded | 8.68M SEK |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Swedencare is a Swedish company that develops and markets health and nutrition products for pets, chiefly dogs and cats. Its range covers dental care supplements, joint and skin support, and everyday wellbeing products sold under its own brands. Customers are mainly pet owners, reached through pet specialty retailers, veterinary channels and online shops in Sweden and abroad. The company is based in Sweden and works with partners to distribute its products in international markets.
The shares are listed on the Stockholm Exchange in Sweden under the code SECARE, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Swedencare publ AB (SECARE) trades on the Stockholm Exchange in Sweden. It last closed at SEK 23.55 on 20 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 519 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 26.4% and over the last three months it rose 9.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.2% | ||
| From 52-week high | -41.4% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 9.0% | ||
| 6-month return | -13.6% | ||
| 12-month return, skipping the last month | -33.3% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.1% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 8.68M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +10.3% |
| 3 months | +9.0% |
| 6 months | −13.6% |
| 1 year | −26.4% |
| 3 years | −37.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 22.06 / 25.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2026 | SEK 0.2800 |
| 25 Apr 2025 | SEK 0.2500 |
| 26 Apr 2024 | SEK 0.2300 |
| 2 May 2023 | SEK 0.2200 |
| 29 Apr 2022 | SEK 0.2000 |
| 30 Apr 2021 | SEK 0.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.